Business Description
Valerio Therapeutics
ISIN : FR0010095596
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | -0.49 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.12 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.5 | |||||
3-Year EPS without NRI Growth Rate | -20.4 | |||||
3-Year FCF Growth Rate | -27.3 | |||||
3-Year Book Growth Rate | -36.2 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.47 | |||||
9-Day RSI | 43.9 | |||||
14-Day RSI | 44.24 | |||||
6-1 Month Momentum % | -32.96 | |||||
12-1 Month Momentum % | -56.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.61 | |||||
Days Sales Outstanding | 340.87 | |||||
Days Payable | 2350.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.2 | |||||
Shareholder Yield % | -49.53 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.39 | |||||
Operating Margin % | -1058.5 | |||||
Net Margin % | -1130.22 | |||||
FCF Margin % | -1043.33 | |||||
ROE % | -101.3 | |||||
ROA % | -49.87 | |||||
ROIC % | -66.78 | |||||
ROC (Joel Greenblatt) % | -1156.41 | |||||
ROCE % | -65.81 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.5 | |||||
PB Ratio | 1.06 | |||||
EV-to-EBIT | -0.89 | |||||
EV-to-EBITDA | -0.97 | |||||
EV-to-Revenue | 9.94 | |||||
EV-to-FCF | -0.95 | |||||
Price-to-Median-PS-Value | 0.68 | |||||
Earnings Yield (Greenblatt) % | -112.36 | |||||
FCF Yield % | -119.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Valerio Therapeutics Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.8 | ||
EPS (TTM) (€) | -0.15 | ||
Beta | 2.63 | ||
Volatility % | 40.55 | ||
14-Day RSI | 44.24 | ||
14-Day ATR (€) | 0.004874 | ||
20-Day SMA (€) | 0.10529 | ||
12-1 Month Momentum % | -56.39 | ||
52-Week Range (€) | 0.09 - 0.348 | ||
Shares Outstanding (Mil) | 154 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Valerio Therapeutics Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Valerio Therapeutics Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Valerio Therapeutics Frequently Asked Questions
What is Valerio Therapeutics(XPAR:ALVIO)'s stock price today?
When is next earnings date of Valerio Therapeutics(XPAR:ALVIO)?
Does Valerio Therapeutics(XPAR:ALVIO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |